scispace - formally typeset
E

Edward C. Goodwin

Researcher at Yale University

Publications -  16
Citations -  2570

Edward C. Goodwin is an academic researcher from Yale University. The author has contributed to research in topics: Bovine papillomavirus & Senescence. The author has an hindex of 15, co-authored 16 publications receiving 2263 citations.

Papers
More filters
Journal ArticleDOI

Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase

TL;DR: It is demonstrated here that SA‐β‐gal activity is expressed from GLB1, the gene encoding lysosomal β‐D‐galactosidase, the activity of which is typically measured at acidic pH 4.5.
Journal ArticleDOI

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

TL;DR: This dynamic response strongly suggests that the p53 and Rb tumor suppressor pathways are intact in HeLa cells and that repression of HPV E6 and E7 mobilizes these pathways in an orderly fashion to deliver growth inhibitory signals to the cells.
Journal ArticleDOI

Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells

TL;DR: It is demonstrated that continuous expression of both the E6 and the E7 protein is required for optimal proliferation of cervical carcinoma cells and that the two viral proteins exert distinct effects on cell survival and proliferation.
Journal ArticleDOI

Rapid induction of senescence in human cervical carcinoma cells

TL;DR: It is proposed that the human papillomavirus E6 and E7 proteins actively prevent senescence from occurring in cervical carcinoma cells, and that once viral oncogene expression is extinguished, the senescENCE program is rapidly executed.
Journal ArticleDOI

Transactivation-Competent Bovine Papillomavirus E2 Protein Is Specifically Required for Efficient Repression of Human Papillomavirus Oncogene Expression and for Acute Growth Inhibition of Cervical Carcinoma Cell Lines

TL;DR: Interestingly, the transactivation-defective E2 mutants were also markedly defective in their ability to repress transcription of the native human papillomavirus type 18 (HPV18) E6/E7 oncogenes in HeLa cells and of the HPV18 promoter present in a transfected reporter plasmid.